or instability in the gastrointestinal tract. The drug must dissolve sufficiently in the stomach or small intestine to be absorbed into the bloodstream. Poor solubility or permeability can result in low bioavailability. Oral delivery system screening aims to address these challenges by optimizing the formulation for better solubility, stability, and absorption.

Step 2: Choose the Appropriate Oral Delivery System

Various oral delivery systems can be used to enhance drug absorption, including:

• Solid dispersions – Improve the solubility of poorly soluble drugs by dispersing the active ingredient in a solid matrix.
• Liquid-filled capsules – Provide a solution or suspension of the drug for better solubility and absorption.
• Nanoparticles – Enhance solubility and bioavailability by reducing the particle size of the drug.
• Prodrugs – Modify the drug molecule to improve solubility and stability before converting back to its active form in the body.

The choice of oral delivery system depends on the drug’s physicochemical properties, such as solubility and permeability, as well as the desired therapeutic effect.

Step 3: Prepare the Formulation for Screening

Once the appropriate oral delivery system is selected, the next step is to prepare the formulation. This involves mixing the active pharmaceutical ingredient (API) with excipients to create a stable and effective oral formulation. Excipients used in oral delivery formulations may include:

• Binders – To hold the tablet or capsule together.
• Disintegrants – To ensure the tablet breaks apart in the gastrointestinal tract for drug release.
• Solubilizers – To improve the solubility of poorly soluble drugs.
• Surfactants – To enhance the dissolution of the drug in the gastrointestinal environment.

Formulation preparation should focus on ensuring that the drug is in the optimal form for absorption in the gastrointestinal tract.

Step 4: Conduct In Vitro Dissolution Testing

Dissolution testing is crucial for evaluating how quickly and efficiently the drug is released from the oral formulation. In vitro dissolution tests simulate the conditions of the gastrointestinal tract, allowing researchers to assess the release profile of the drug. This test helps determine whether the oral delivery system effectively enhances drug solubility and whether the drug will be absorbed adequately in vivo.

Step 5: Perform Pharmacokinetic Testing

Pharmacokinetic studies measure the drug’s absorption, distribution, metabolism, and elimination in the body. These studies help assess the bioavailability of the drug after oral administration. By performing pharmacokinetic testing, researchers can determine whether the oral delivery system enhances the drug’s absorption and bioavailability compared to its pure form.

Step 6: Evaluate Formulation Stability

Stability testing is essential to ensure that the oral delivery system maintains its integrity over time. The formulation should remain stable under different storage conditions, such as temperature, humidity, and light exposure. Stability testing helps predict the shelf life of the formulation and ensures that the drug will not degrade or lose potency during storage.

Step 7: Optimize the Formulation

If initial screening results indicate that the oral delivery system is not providing the desired release profile or bioavailability, formulation optimization may be necessary. This may involve adjusting the excipient concentrations, changing the delivery system, or modifying the manufacturing process to improve solubility and absorption.

In conclusion, conducting oral delivery system screening is essential for improving the solubility and bioavailability of poorly soluble drugs. By selecting the right oral delivery system, optimizing formulation parameters, and conducting thorough testing, researchers can develop effective oral formulations that enhance drug absorption and therapeutic efficacy.